Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Laboratory implementation of human papillomavirus testing.

David R Bolick1, Randall E Bolick, Faye Coates

  • 1AmeriPath-Utah, Sandy, Utah 84070, USA. bolick@rpslab.com

Archives of Pathology & Laboratory Medicine
|July 23, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Clinical Validity and Utility of PCR Compared to Conventional Culture and Sensitivity Testing for the Management of Complicated Urinary Tract Infections in Adults: A Secondary (Ad Hoc) Analysis of Pathogen Detection, Resistance Profiles, and Impact on Clinical Outcomes.

Microorganisms·2025
Same author

Corrigendum to "Clinical utility of PCR compared to conventional culture & sensitivity testing for the management of complicated urinary tract infections in adults:Part I. Assessment of clinical outcomes,investigator satisfaction scores & turnaround times" [Diagnostic Microbiology & Infectious Disease 111 (2025) 116601].

Diagnostic microbiology and infectious disease·2025
Same author

Clinical utility of PCR compared to conventional culture and sensitivity testing for management of complicated urinary tract infections in adults: Part II.Evaluation of diagnostic concordance, discordant results, and antimicrobial selection efficacy.

Diagnostic microbiology and infectious disease·2024
Same author

Clinical utility of PCR compared to conventional culture and sensitivity testing for the management of complicated urinary tract infections in adults: Part I. Assessment of clinical outcomes, investigator satisfaction scores, and turnaround times.

Diagnostic microbiology and infectious disease·2024
Same author

A Diagnostic Conundrum - Small bowel obstruction from undiagnosed endometriosis following uterine perforation.

International journal of surgery case reports·2023
Same author

Insights from a workplace SARS-CoV-2 specimen collection program, with genomes placed into global sequence phylogeny.

PloS one·2023

Implementing human papillomavirus (HPV) testing is crucial for cervical cancer screening. This guide helps laboratories navigate developing HPV testing services, covering methodology, in-house vs. send-out options, and financial management.

Area of Science:

  • Oncology
  • Virology
  • Laboratory Medicine

Background:

  • Cervical cancer screening increasingly incorporates human papillomavirus (HPV) testing.
  • Laboratories performing Papanicolaou tests face market demands to integrate HPV testing.
  • Developing a robust HPV testing service is becoming essential for clinical laboratories.

Purpose of the Study:

  • To provide guidance for laboratories establishing human papillomavirus (HPV) testing services.
  • To address key considerations in implementing HPV testing within a laboratory setting.
  • To assist laboratories in making informed decisions regarding HPV testing methodologies and operational models.

Main Methods:

  • The study presents data and information to facilitate laboratory decision-making.

Related Experiment Videos

  • It outlines critical issues for developing an HPV testing service.
  • Discussion includes methodology selection, in-house versus external testing, and implementation strategies.

    • Main Results:

    • Key factors for selecting an appropriate HPV testing methodology are discussed.
    • Analysis of in-house versus send-out testing models is provided.
    • Guidance on initiating an HPV testing service and managing financial aspects is offered.

    Conclusions:

    • Laboratories need to strategically plan for the integration of human papillomavirus (HPV) testing.
    • Informed decisions on methodology, service model, and financial management are vital for successful implementation.
    • Proactive development of HPV testing services supports comprehensive cervical cancer screening programs.